The Drug Pricing Landscape in 2023: Renewed Pressure for Pricing Reform
For over a decade, industry watchdogs, patient groups and various lawmakers have been calling for drug pricing reform—initially with...
Kristen Riemenschneider's Passles
Freshfields Technology Quotient
Insights at the intersection of technology and the law
Most Read
2023 J.P. Morgan Healthcare Conference Highlights
The 41st Annual J.P. Morgan Healthcare Conference, held in-person for the first time in three years, was a tale of two cities – marked...
Inflation Reduction Act Price Negotiation
On August 16, 2022, U.S. President Joe Biden signed into law the Inflation Reduction Act, which requires the Secretary of the Department...
Life Sciences Licensing and Collaboration Deals: Antitrust Traps for the Unwary
With an uptick in antitrust enforcement action across the US, UK, EU and China (among other jurisdictions), companies in the life...
Could the Specter of March-In Rights Finally Impact Drug Pricing Reform?
On March 24, 2022 a group of public interest organizations filed a petition urging the Department of Health and Human Services (“HHS”) to...
As a free user, you can follow Passle and like posts.
To repost this post to your own Passle blog, you will need to upgrade your account.
For plans and pricing, please contact our sales team at sales@passle.net
